Clinical trial
A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of XG005 Tablets in Subjects Undergoing Bunionectomy
NCT06017999 is registered in ClinicalTrials.gov with Xgene Pharmaceutical Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of XG005 Tablets in Subjects Undergoing Bunionectomy
- Lead sponsor
- Xgene Pharmaceutical Group
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 29, 2023
- Completion date
- September 30, 2024
- Enrollment
- 450 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.